Medication
Vabysmo
DIN 02554003 · Hoffmann-LA Roche Limited
What it is
- Active ingredients
- Faricimab — 6 mg
- Form and route
- Solution · Intravitreal
- Schedule
- PRESCRIPTION, SCHEDULE D
- Authorised since
- 2025-06-30
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
How it is classified
- Anatomical main group
- Sensory organs
- ATC code
- S01LA09
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of S01LA09, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.